Back
EACVI Premium Access

CMR biomarkers as endpoints in STEMI clinical trial design – which most indicates treatment success.

Session: Short Lecture 3 - Clinical Trials and Drug Development by CMR
Topic: Cardiac Magnetic Resonance (CMR)
Speaker: Professor G. McCann (Leicester, GB)
Event: CMR 2018 (the 5th joint EuroCMR/SCMR meeting)

Congress Presentation

Add to my library

Like

About the speaker

Professor Gerry McCann

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

2 more presentations in this session

CMR Clinical Trials in Coronary Artery Disease: lessons and future directions.

Speaker: Professor J. Greenwood (Melbourne, AU)

Access
Slides
Like
Thumbnail

How imaging can become a key player in the future of clinical trial and drug development.

Speaker: Doctor R. Kwong (Boston, US)

Access
Slides
Like
Thumbnail

Access the full session

Short Lecture 3 - Clinical Trials and Drug Development by CMR

Speakers: Professor G. McCann, Professor J. Greenwood, Doctor R. Kwong
Access
Like
Thumbnail

About the event

Image

CMR 2018 (the 5th joint EuroCMR/SCMR meeting)

31 January - 3 February 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources